389 related articles for article (PubMed ID: 19891732)
21. Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene.
Kreek MJ; LaForge KS
Mol Interv; 2007 Apr; 7(2):74-8. PubMed ID: 17468387
[TBL] [Abstract][Full Text] [Related]
22. Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms.
Ide S; Kobayashi H; Ujike H; Ozaki N; Sekine Y; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Iwata N; Tanaka K; Shen H; Iwahashi K; Itokawa M; Minami M; Satoh M; Ikeda K; Sora I
Pharmacogenomics J; 2006; 6(3):179-88. PubMed ID: 16402083
[TBL] [Abstract][Full Text] [Related]
23. A118G mu opioid receptor polymorphism among drug addicts in Malaysia.
Nagaya D; Ramanathan S; Ravichandran M; Navaratnam V
J Integr Neurosci; 2012 Mar; 11(1):117-22. PubMed ID: 22744787
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
[TBL] [Abstract][Full Text] [Related]
25. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.
Zhang Y; Wang D; Johnson AD; Papp AC; Sadée W
J Biol Chem; 2005 Sep; 280(38):32618-24. PubMed ID: 16046395
[TBL] [Abstract][Full Text] [Related]
26. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
27. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia.
Zhang W; Yuan JJ; Kan QC; Zhang LR; Chang YZ; Wang ZY
Minerva Anestesiol; 2011 Jan; 77(1):33-9. PubMed ID: 21150856
[TBL] [Abstract][Full Text] [Related]
28. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
29. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
31. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
Daher M; Costa FM; Neves FA
Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine hydroxylase phosphorylation after naloxone-induced morphine withdrawal in the left ventricle.
Almela P; Victoria Milanés M; Luisa Laorden M
Basic Res Cardiol; 2009 Jul; 104(4):366-76. PubMed ID: 19104749
[TBL] [Abstract][Full Text] [Related]
33. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Milanés MV
J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
[TBL] [Abstract][Full Text] [Related]
34. A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.
Kapur S; Sharad S; Singh RA; Gupta AK
J Integr Neurosci; 2007 Dec; 6(4):511-22. PubMed ID: 18181266
[TBL] [Abstract][Full Text] [Related]
35. Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells.
Falktoft B; Georg B; Fahrenkrug J
Neuropeptides; 2009 Oct; 43(5):387-96. PubMed ID: 19712974
[TBL] [Abstract][Full Text] [Related]
36. Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities.
Sadée W; Wang D; Bilsky EJ
Life Sci; 2005 Feb; 76(13):1427-37. PubMed ID: 15680308
[TBL] [Abstract][Full Text] [Related]
37. Association of polymorphism in the human mu-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception.
Matsunaga M; Isowa T; Murakami H; Kasugai K; Yoneda M; Kaneko H; Ohira H
Brain Behav Immun; 2009 Oct; 23(7):931-5. PubMed ID: 19341791
[TBL] [Abstract][Full Text] [Related]
38. Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala.
Befort K; Filliol D; Ghate A; Darcq E; Matifas A; Muller J; Lardenois A; Thibault C; Dembele D; Le Merrer J; Becker JA; Poch O; Kieffer BL
Eur J Neurosci; 2008 Jun; 27(11):2973-84. PubMed ID: 18588537
[TBL] [Abstract][Full Text] [Related]
39. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
Kumar D; Chakraborty J; Das S
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):225-30. PubMed ID: 22138325
[TBL] [Abstract][Full Text] [Related]
40. Gene polymorphisms of the mu opioid receptor in methamphetamine abusers.
Ide S; Kobayashi H; Tanaka K; Ujike H; Sekine Y; Ozaki N; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Ikeda K; Sora I
Ann N Y Acad Sci; 2004 Oct; 1025():316-24. PubMed ID: 15542732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
